Product News

Surface Treatment

  • MCTec B.V.
    Originally Published EMDM September 2002 PRODUCT UPDATE Using a proprietary continuous coating process, a company applies a biocompatible material to metal and plastic parts. The spool-to-spool process produces smoother wires with a more consistent diameter than spray coating, according...
    (September, 2002)
  • Conformal polymer coating insulates and protects sensitive components
    Originally Published EMDM May/June 2002 SURFACE TREATMENT A Swiss company specializes in parylene vacuum surface treatment. Comelec S.A. (La Chaux-de-Fonds) carries out galxyl or parylene treatment in its workshops on a contract basis. The galxyl coating process is carried out under a vacuum ...
    (May, 2002)
  • Increasing Functionality on the Surface
    Originally Published EMDM January/February 2002 SPECIAL REPORT Increasing Functionality on the Surface Return to Article: Making it Smaller: Manufacturing Minimally Invasive Devices Surface coatings have long...
    (January, 2002)
  • In Quest to Eliminate Biofilm, Baker's Yeast Rises to the Challenge
    The study of yeast cells may point a way toward eliminating the formation of biofilm on medical devices and implants, according to microbiologists at the Whitehead Institute for Biomedical Research in Cambridge, MA, USA. Fungal growth caused by Candida albicans envelops devices in a resil...
    (May, 2001)
  • Laser Deposition Technique Creates Thin Coatings on Implants
    SURFACE TREATMENT Hip and knee implants are expected to benefit from a company's coating of hydroxylapatite applied via pulsed laser deposition. Introduced in February at the Micro and Nano Technologies in the Life Sciences conference in Zürich, Switzerland, a company's technique ...
    (May, 2001)
  • Spire Corp. Forms Medical Subsidiary
    Spire Corp. (Bedford, MA, USA) has completed a corporate restructuring, resulting in the formation of Spire Biomedical Inc. (SBI) in January. SBI applies biotechnology surface engineering to implantable medical devices, primarily in the orthopaedic and cardiovascular markets. For more inf...
    (March, 2001)